戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1072263作成日:2026年10月25日

(RS)-N,N-dimethyl-{2-[4-(alpha-phenyl-p-chloro-benzyl)piperazin-1-yl]ethoxy}-acetamide → Cetirizine Hydrochloride

https://huagongshe.com/reaction/1072263

反応式

関与物質

役割名称HCID仕込み量
反応物(RS)-N,N-dimethyl-{2-[4-(alpha-phenyl-p-chloro-benzyl)piperazin-1-yl]ethoxy}-acetamideHCID 10180126—
反応物(RS)-N,N-diethyl-{2-[4-(alpha-phenyl-p-chloro-benzyl)piperazin-1-yl]ethoxy}-acetamideHCID 22391920—
溶媒1,4-DioxaneHCID 31275—
生成物Cetirizine HydrochlorideHCID 5518274.9%

反応手順

The procedure described in Example 14 is followed with the difference that, instead of the (RS)-N,N-dimethyl-{2-[4-(α-phenyl-p-chloro-benzyl)piperazin-1-yl]ethoxy}-acetamide, 104.4 g (0.2 moles) of (RS)-N,N-diethyl-{2-[4-(α-phenyl-p-chloro-benzyl)piperazin-1-yl]ethoxy}-acetamide are used, 100 ml of dioxane are employed as cosolvent, and, during the alkaline hydrolysis, the reaction mixture is boiled for 4 hours. Thus, 69.1 g (74.9%) of the title compound are obtained, m.p.: 225-228° C. The purity of the product corresponds to the quality requirements given in Eur. Pharm., 3, 1997, 1084.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US06908999B2
出典データセットuspto-grants-2005_06
ORD IDord-daf8c77284af4de28b716c7be08bfd2d
出典メモuspto-grants-2005_06